|
|
|
Volumn 79, Issue 7, 2013, Pages
|
|
Top 200 drugs of 2012
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
ABIRATERONE ACETATE;
ADALIMUMAB;
ALENDRONIC ACID;
ALPRENOLOL;
ALTEPLASE;
AMLODIPINE PLUS VALSARTAN;
AMOXICILLIN;
AMPHETAMINE;
ARIPIPRAZOLE;
ATAZANAVIR;
ATOMOXETINE;
ATORVASTATIN;
AZITHROMYCIN;
BECLOMETASONE DIPROPIONATE;
BENDAMUSTINE;
BETA1A INTERFERON;
BEVACIZUMAB;
BUDESONIDE;
BUDESONIDE PLUS FORMOTEROL;
BUPRENORPHINE PLUS NALOXONE;
CAPECITABINE;
CARVEDILOL;
CEFALEXIN;
CELECOXIB;
CHOLINE FENOFIBRATE;
CIPROFLOXACIN PLUS DEXAMETHASONE;
CLONAZEPAM;
CLOPIDOGREL;
COLCHICINE;
COLESEVELAM;
CONJUGATED ESTROGEN;
DASATINIB;
DENOSUMAB;
DESVENLAFAXINE;
DEXMETHYLPHENIDATE;
DIAZEPAM;
DIPHTHERIA PERTUSSIS TETANUS VACCINE;
DORNASE ALFA;
DULOXETINE;
EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
EMTRICITABINE PLUS RILPIVIRINE PLUS TENOFOVIR DISOPROXIL;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ENOXAPARIN;
ERLOTINIB;
ESCITALOPRAM;
ESOMEPRAZOLE;
ESZOPICLONE;
ETANERCEPT;
EVEROLIMUS;
EZETIMIBE;
EZETIMIBE PLUS SIMVASTATIN;
FENOFIBRATE;
FLUOXETINE;
FLUTICASONE PROPIONATE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE;
GLATIRAMER;
GOLIMUMAB;
HUMAN GROWTH HORMONE;
HYCD APAP;
HYDROCHLOROTHIAZIDE;
HYDROCHLOROTHIAZIDE PLUS OLMESARTAN;
HYDROCHLOROTHIAZIDE PLUS VALSARTAN;
IMATINIB;
INFLIXIMAB;
INSULIN GLARGINE;
INSULIN LISPRO;
IPILIMUMAB;
ISOTRETINOIN;
LANTUS SOLOSTAR;
LEVOTHYROXINE SODIUM;
LIDOCAINE;
LINEZOLID;
LISDEXAMFETAMINE;
LISINOPRIL;
MEMANTINE;
MESALAZINE;
METFORMIN;
METFORMIN PLUS SITAGLIPTIN;
METHYLPHENIDATE ER;
MODAFINIL;
MONTELUKAST;
NEBIVOLOL;
NICOTINIC ACID;
NILOTINIB;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
OCTREOTIDE;
OLANZAPINE;
OLMESARTAN;
OMALIZUMAB;
OMEGA 3 ACID ETHYL ESTER;
OXALIPLATIN;
OXYCODONE;
PALIVIZUMAB;
PARATHYROID HORMONE[1-34];
PEGINTERFERON ALPHA2A;
PEMETREXED;
PIOGLITAZONE;
PIPERACILLIN PLUS TAZOBACTAM;
PNEUMOCOCCUS VACCINE;
PRASUGREL;
PRAVASTATIN;
PREGABALIN;
PRESCRIPTION DRUG;
QUETIAPINE;
RALTEGRAVIR;
RANIBIZUMAB;
RANOLAZINE;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITONAVIR;
RITUXIMAB;
RIZATRIPTAN;
ROSUVASTATIN;
SALBUTAMOL SULFATE;
SAXAGLIPTIN;
SEVELAMER CARBONATE;
SILDENAFIL;
SIMVASTATIN;
SITAGLIPTIN;
SUNITINIB;
TADALAFIL;
TELAPREVIR;
TESTOSTERONE;
TIOTROPIUM BROMIDE;
TOLTERODINE;
TRAMADOL;
TRAVOPROST;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
USTEKINUMAB;
VALSARTAN;
VARENICLINE;
VARICELLA ZOSTER VACCINE;
VENLAFAXINE;
VITAMIN D;
WARFARIN;
WART VIRUS VACCINE;
ZIPRASIDONE;
ZOLEDRONIC ACID;
ARTICLE;
DRUG COST;
DRUG SAFETY;
EMERGENCY WARD;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE COST;
HEALTH CARE UTILIZATION;
HEALTH INSURANCE;
HEALTH SERVICE;
HOSPITALIZATION;
HUMAN;
OUTCOME ASSESSMENT;
PATIENT COMPLIANCE;
PRESCRIPTION;
|
|
EID: 84880668750
PISSN: 00030627
EISSN: None
Source Type: Trade Journal
DOI: None Document Type: Article |
|
Times cited : (23)
|
|
References (1)
|
